
Supinda Bunyavanich
- ASSISTANT PROFESSOR Pediatrics
- ASSISTANT PROFESSOR Genetics and Genomic Sciences
Print Profile
Specialty
Certifications
American Board of Allergy & Immunology
American Board of Internal Medicine
Clinical Focus
Education
MD, Harvard Medical School
Residency, Internal Medicine
Massachusetts General HospitalFellowship, Allergy & Immunology
Brigham & Women's Hospital
Publications
Nicolai S, Bunyavanich S. Hypersensitivity reaction to intravenous but not oral tacrolimus. Transplantation 2012 Nov; 94(9): e61-3.
Rogers A, Bunyavanich S. Unravelling gene-by-environment effects in asthma and allergy: the glutathione pathway as an early success story. Clin Exp Allergy 2011 Nov; 41(11): 1502-4.
Bunyavanich S, Boyce J, Raby B, Weiss S. Gene-by-environment effect of house dust mite on purinergic receptor P2Y12 (P2RY12) and lung function in children with asthma. Clin Exp Allergy 2012 Feb; 42(2): 42(2).
Bunyavanich S, Shargorodsky J, Celedón J. A meta-analysis of Th2 pathway genetic variants and risk for allergic rhinitis. . Pediatr Allergy Immunol 2011 Jun; 22(4): 378-87.
Bunyavanich S, Melen E, Wilk J, Granada M, Soto-Quiros M, Avila L, Lasky-Su J, Hunninghake G, Wickman M, Pershagen G, O'Connor G, Weiss S, Celedón J. Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. . Clin Mol Allergy 2011 Jan; 18: 9:1.
Lange N, Bunyavanich S, Silberg J, Canino G, Rosner B, Celedón J. Parental psychosocial stress and asthma morbidity in Puerto Rican twins. . J Allergy Clin Immunol 2011 Mar; 127(3): 734-40.
Bunyavanich S, Soto-Quiros M, Avila L, Laskey D, Senter J, Celedón J. Risk factors for allergic rhinitis in Costa Rican children with asthma. . Allergy 2010 Feb; 65(2): 256-63.
Bunyavanich S, Landrigan C, McMichael A, Epstein P. The impact of climate change on child health. . Ambul Pediatr 2003 Jan-Feb; 3(1): 44-52.
Bunyavanich S, Walkup R. US public health leaders shift toward a new paradigm of global health.. Am J Public Health 2001 Oct; 91(10): 1556-8.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Bunyavanich is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 17 Room 90
1468 Madison Avenue
New York, NY 10029
Faculty Practice Associates Floor 10
5 East 98th Street
New York, NY 10029

